Ans .Prior to being placed on the market, the ICL was subject to extensive research and development. Today, more than 65,000 patients worldwide enjoy the benefits of the device. In an USFDA clinical trial, over 99 percent of patients were satisfied with their implant.
The ICL has a track record of stable, consistently excellent clinical outcomes. The lens has been available internationally for over 12 years.
Posted in: Implantable Contact Lens